Page last updated: 2024-09-03

imatinib mesylate and Febrile Neutropenia

imatinib mesylate has been researched along with Febrile Neutropenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boissel, N; Borthakur, G; Brummendorf, TH; Capolongo, L; Carpinelli, P; Cortes, JE; Davite, C; Dombret, H; Jabbour, E; Kantarjian, H; Mariani, M; Schafhausen, P	1

Trials

1 trial(s) available for imatinib mesylate and Febrile Neutropenia

Article	Year
A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c- Haematologica, 2015, Volume: 100, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Blast Crisis; Drug Administration Schedule; Febrile Neutropenia; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mucositis; Mutation; Philadelphia Chromosome; Protein Kinase Inhibitors; Pyrazoles	2015

Article

Year

A phase I study of danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-

Haematologica, 2015, Volume: 100, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Blast Crisis; Drug Administration Schedule; Febrile Neutropenia; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Male; Middle Aged; Mucositis; Mutation; Philadelphia Chromosome; Protein Kinase Inhibitors; Pyrazoles

2015